NL-OMON53777招募中不适用
HYpofractionated, Dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma - HYDRA trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 154
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •patients with squamous cell carcinoma of the oropharynx, hypopharynx and larynx
- •who are eligible for curative intent proton or photon therapy, with or without
- •concurrent radiosensitizer
排除标准
- •Previously treated by irradiation in the head and neck region
- •Chronic inflammatory disease or immune disorders
- •Other malignant disease (unless in situ carcinoma or BCC) within the last 2
研究者
相似试验
已完成
2 期
Intensity-modulated, hypofractionated radiotherapy with scanning beam protons for locally advanced carcinoma of the prostate and localized carcinoma of the prostate with risk factors - a phase II studyC61Malignant neoplasm of prostateDRKS00011912Westdeutsches Protonentherapiezentrum Essen (WPE)133
招募中
3 期
Standard moderately hypofractionated radiotherapy vs. ultra-hypofractionated focal lesion ablative microboost in prostate cancer, Hypo-FLAME 3.010038597prostate cancerNL-OMON56327Antoni van Leeuwenhoek Ziekenhuis352
进行中（未招募）
不适用
Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancerKCT0005443ational Cancer Center35
尚未招募
2 期
Higher cumulative dose, 6days/week vs standard, 5days/week moderately hypofractionated palliative radiotherapy with concurrent chemotherapy in locally advanced head and neck carcinoma.CTRI/2023/10/058621AIIMS, New Delhi
招募中
2 期
Two-fraction Ultra-hypofractionated Radiotherapy with Focal Boost for low- and intermediate risk, localized prostate cancer (TURBO):phase II, randomized controlled clinical trialprostate adenocarcinoma100276561001818810036958prostate cancerNL-OMON56580niversitair Medisch Centrum Utrecht160